Login
Password
Remember Me
FEATURE STORY ● Artificial intelligence approach to create AAV capsids for gene therapies DISRUPTIVE TECHNOLOGIES ● Nanoparticles as carriers for drug...
Two Chinese companies invest in Vigeneron, a German firm developing ophthalmological gene therapy programs The German gene therapy company Vigeneron has...
More than 580 gene therapy products are under development in biotech and pharmaceutical companies for the treatment of more than 240...
More articles from NEWS
How to increase the number of European-based ATMP clinical trials? The latest report published by the Alliance for Regenerative Medicine (ARM),...
BioPharmAnalyses and OctopusyX BioConsulting are proud to announce the launch of their up-dated and enriched 2019 edition of their report...
300 million people living with a rare disease worldwide An open-access article, written by Orphanet (coordinated by INSERM, the French National...
More articles from ANALYSES
An artificial intelligence approach to create AAV capsids for gene therapies Adeno-associated viruses (AAVs) have become the go-to vehicle for delivering...
Transforming DNA repair errors into assets A new bioinformatics tool, MHcut, developed by researchers in Kyoto, Japan, and Montreal, Canada, reveals that...
Accumulation of DNA mutations found in healthy liver leads to disease New insights into the journey from health to disease in...
More articles from SCIENTIFIC NEWS
